Advertisement
Advertisement
USNA
USANA Health Sciences Inc
17.63
USDSponsored
-0.20
-1.13%
Mar 09, 16:00 UTC -4
Closed
After-Market
17.63
0.00
-0.02%
USNA Earnings Reports
Positive Surprise Ratio
USNA beat 24 of 40 last estimates.
60%
Next Report
Date of Next Report
Apr 20, 2026
Estimate for Q1 26 (Revenue/ EPS)
$245.76M
/$0.44
Implied change from Q4 25 (Revenue/ EPS)
+8.65%
/-26.67%
Implied change from Q1 25 (Revenue/ EPS)
-1.51%
/-39.73%
USANA Health Sciences Inc earnings per share and revenue
On Feb 17, 2026, USNA reported earnings of 0.60 USD per share (EPS) for Q4 25, beating the estimate of 0.41 USD, resulting in a 43.47% surprise. Revenue reached 226.20 million, compared to an expected 230.48 million, with a -1.86% difference. The market reacted with a -1.41% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of 0.44 USD, with revenue projected to reach 245.76 million USD, implying an decrease of -26.67% EPS, and increase of 8.65% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.30
Surprise
+18.50%
Bioventus Inc. Class A Common Stock
Report Date
Mar 05, 2026 For Q4 25
Estimate
$0.21
Actual
$0.24
Surprise
+9.69%
Altimmune, Inc. Common Stock
Report Date
Mar 05, 2026 For Q4 25
Estimate
-$0.24
Actual
-$0.27
Surprise
-10.16%
Zevra Therapeutics, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
$0.05
Actual
$1.15
Surprise
+2174.51%
Aquestive Therapeutics, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.26
Surprise
-92.31%
OmniAb, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.11
Surprise
-21.82%
Profound Medical Corp. Common Stock
Report Date
Mar 05, 2026 For Q4 25
Estimate
-$0.26
Actual
-$0.27
Surprise
-0.26%
MediWound Ltd.
Report Date
Mar 05, 2026 For Q4 25
Estimate
-$0.64
Actual
-$0.56
Surprise
+13.08%
Corbus Pharmaceuticals Holdings, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$1.60
Actual
-$1.25
Surprise
+22.24%
Cumberland Pharmaceuticals Inc
Report Date
Mar 03, 2026 For Q4 25
Estimate
-Actual
-$0.01
Surprise
-
FAQ
What were USANA Health Sciences Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, USANA Health Sciences Inc reported EPS of $0.60, beating estimates by 43.47%, and revenue of $226.20M, -1.86% below expectations.
How did the market react to USANA Health Sciences Inc's Q4 2025 earnings?
The stock price moved down -1.41%, changed from $20.60 before the earnings release to $20.31 the day after.
When is USANA Health Sciences Inc expected to report next?
The next earning report is scheduled for Apr 20, 2026.
What are the forecasts for USANA Health Sciences Inc's next earnings report?
Based on 3
analysts, USANA Health Sciences Inc is expected to report EPS of $0.44 and revenue of $245.76M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement